TriSalus Life Sciences, Inc. Quarterly Return On Equity in % from Q2 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
TriSalus Life Sciences, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2021 to Q2 2024.
  • TriSalus Life Sciences, Inc. Return On Equity for the quarter ending June 30, 2024 was 284 %, a 858% increase year-over-year.
  • TriSalus Life Sciences, Inc. annual Return On Equity for 2023 was 59 %, a 91.8% increase from 2022.
  • TriSalus Life Sciences, Inc. annual Return On Equity for 2022 was 30.8 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 284 +254 +858% Apr 1, 2024 Jun 30, 2024
Q1 2024 102 +73.3 +254% Jan 1, 2024 Mar 31, 2024
Q4 2023 59 +28.2 +91.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 33.5 +18.1 +118% Jul 1, 2023 Sep 30, 2023
Q2 2023 29.7 +18.8 +172% Apr 1, 2023 Jun 30, 2023
Q1 2023 28.8 +25.3 +712% Jan 1, 2023 Mar 31, 2023
Q4 2022 30.8 +40.7 Oct 1, 2022 Dec 31, 2022
Q3 2022 15.4 +20.8 Jul 1, 2022 Sep 30, 2022
Q2 2022 10.9 +6.55 +150% Apr 1, 2022 Jun 30, 2022
Q1 2022 3.55 Jan 1, 2022 Mar 31, 2022
Q4 2021 -9.9 Oct 1, 2021 Dec 31, 2021
Q3 2021 -5.5 Jul 1, 2021 Sep 30, 2021
Q2 2021 4.35 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.